Literature DB >> 2822671

Gene transfer from Escherichia coli to Campylobacter species: development of shuttle vectors for genetic analysis of Campylobacter jejuni.

A Labigne-Roussel1, J Harel, L Tompkins.   

Abstract

A shuttle cloning vector (pIL550) has been constructed which can be mobilized from Escherichia coli to Campylobacter jejuni, Campylobacter coli, and Campylobacter fetus by complementation with the transfer functions of an IncP plasmid in trans, with a frequency of 10(-4) transconjugants per donor. We also present evidence for a DNA modification system in C. jejuni.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822671      PMCID: PMC213946          DOI: 10.1128/jb.169.11.5320-5323.1987

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  12 in total

1.  A complementation analysis of the restriction and modification of DNA in Escherichia coli.

Authors:  H W Boyer; D Roulland-Dussoix
Journal:  J Mol Biol       Date:  1969-05-14       Impact factor: 5.469

Review 2.  Pathophysiology of Campylobacter enteritis.

Authors:  R I Walker; M B Caldwell; E C Lee; P Guerry; T J Trust; G M Ruiz-Palacios
Journal:  Microbiol Rev       Date:  1986-03

3.  The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers.

Authors:  J Vieira; J Messing
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

4.  Structural relationship between the genes encoding 3'-aminoglycoside phosphotransferases in Campylobacter and in gram-positive cocci.

Authors:  T Lambert; G Gerbaud; P Trieu-Cuot; P Courvalin
Journal:  Ann Inst Pasteur Microbiol (1985)       Date:  1985 Sep-Oct

5.  Experimental infection of gnotobiotic mice with Campylobacter jejuni: colonisation of intestine and spread to lymphoid and reticulo-endothelial organs.

Authors:  J L Fauchère; M Véron; A Lellouch-Tubiana; A Pfister
Journal:  J Med Microbiol       Date:  1985-10       Impact factor: 2.472

6.  Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate.

Authors:  R A Hull; R E Gill; P Hsu; B H Minshew; S Falkow
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

7.  Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans.

Authors:  D H Figurski; D R Helinski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

8.  Construction and characterization of new cloning vehicles. II. A multipurpose cloning system.

Authors:  F Bolivar; R L Rodriguez; P J Greene; M C Betlach; H L Heyneker; H W Boyer; J H Crosa; S Falkow
Journal:  Gene       Date:  1977       Impact factor: 3.688

9.  Conjugal transfer of bacterial chromosomes mediated by the RK2 plasmid transfer origin cloned into transposon Tn5.

Authors:  E A Yakobson; D G Guiney
Journal:  J Bacteriol       Date:  1984-10       Impact factor: 3.490

10.  Plasmid transfer from Escherichia coli to Bacteroides fragilis: differential expression of antibiotic resistance phenotypes.

Authors:  D G Guiney; P Hasegawa; C E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

View more
  49 in total

1.  Detection on surfaces and in Caco-2 cells of Campylobacter jejuni cells transformed with new gfp, yfp, and cfp marker plasmids.

Authors:  W G Miller; A H Bates; S T Horn; M T Brandl; M R Wachtel; R E Mandrell
Journal:  Appl Environ Microbiol       Date:  2000-12       Impact factor: 4.792

2.  Molecular cloning and site-specific mutagenesis of a gene involved in arylsulfatase production in Campylobacter jejuni.

Authors:  R Yao; P Guerry
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

3.  Characterization of Helicobacter pylori dapE and construction of a conditionally lethal dapE mutant.

Authors:  M Karita; M L Etterbeek; M H Forsyth; M K Tummuru; M J Blaser
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Biosynthetic pathway for mannopeptimycins, lipoglycopeptide antibiotics active against drug-resistant gram-positive pathogens.

Authors:  Nathan A Magarvey; Brad Haltli; Min He; Michael Greenstein; John A Hucul
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

5.  Altered linkage of hydroxyacyl chains in lipid A of Campylobacter jejuni reduces TLR4 activation and antimicrobial resistance.

Authors:  Andries van Mourik; Liana Steeghs; Jacoline van Laar; Hugo D Meiring; Hendrik-Jan Hamstra; Jos P M van Putten; Marc M S M Wösten
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

6.  Growth phase-dependent activation of the DccRS regulon of Campylobacter jejuni.

Authors:  Marc M S M Wösten; Linda van Dijk; Craig T Parker; Magalie R Guilhabert; Ynske P M van der Meer-Janssen; Jaap A Wagenaar; Jos P M van Putten
Journal:  J Bacteriol       Date:  2010-03-26       Impact factor: 3.490

7.  Dispersal in Campylobacter spp. of aphA-3, a kanamycin resistance determinant from gram-positive cocci.

Authors:  B Papadopoulou; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

8.  Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection.

Authors:  N R Salama; G Otto; L Tompkins; S Falkow
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

9.  In vivo tracking of Campylobacter jejuni by using a novel recombinant expressing green fluorescent protein.

Authors:  Philip F Mixter; John D Klena; Gary A Flom; Amy M Siegesmund; Michael E Konkel
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

10.  Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance.

Authors:  Amera Gibreel; Dobryan M Tracz; Lisa Nonaka; Trinh M Ngo; Sean R Connell; Diane E Taylor
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.